FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4284672912> ?p ?o ?g. }

• W4284672912 endingPage "507" @default.
• W4284672912 startingPage "495" @default.
• W4284672912 abstract "Although several studies from Europe and the US have shown promising screening results favoring digital breast tomosynthesis compared with standard digital mammography (DM), both costs and effects of implementing tomosynthesis in routine screening programs remain uncertain. The cost effectiveness of using tomosynthesis in routine screening is debated in the literature, and model inputs from randomized trials are lacking. Using parameters mainly from a randomized controlled trial (the To-Be trial), we simulated costs and effects of implementing tomosynthesis in the national screening program BreastScreen Norway. The To-Be trial was performed in Bergen from 2016 to 2017 within BreastScreen Norway, where females were randomized to either digital breast tomosynthesis including synthetic mammograms (DBT) or DM. The trial was followed by a cohort study offering all females DBT in 2018–2019. The trial included over 37,000 females, and allowed for estimation of short-term costs and effects related to screening, recall examinations and cancer detection. Using these and recent Norwegian estimates for 10-year stage-specific survival and treatment costs, the cost effectiveness of replacing DM with DBT in BreastScreen Norway was simulated in a decision tree model with probabilistic sensitivity analyses. Outcomes included false-positive screening results, screen-detected and interval cancers, stage at diagnosis, all-cause deaths, life-years gained, costs at recall and treatment and incremental cost-effectiveness ratio. The estimated additional cost of DBT was €8.10. Simulating ten rounds of screening from 2018 and 10-year survival and costs, 500 deaths were averted and 2300 life-years gained at an additional screening cost of €29 million for females screened with DBT versus DM. Taking over-diagnosis, recall and treatment costs into account, DBT was dominant in the deterministic analysis. The incremental cost-effectiveness ratio indicated cost savings of €1400 per life-year gained. Probabilistic sensitivity analyses showed that DBT was cost effective in over 50% of the simulations at all willingness-to-pay levels per life-year gained, and in 80% of the simulations at levels above €22,000. If willingness-to-pay levels up to €35,000 were assumed, DBT would be cost effective in over 50% of the simulations for additional costs of DBT of up to €32, almost four times the estimated additional cost of €8.10. DBT may be cost effective if implemented in BreastScreen Norway. However, generalizability of results could depend on factors varying between countries, such as recall rates, program sensitivity and specificity, treatment cost and willingness-to-pay levels." @default.
• W4284672912 created "2022-07-08" @default.
• W4284672912 creator A5009549265 @default.
• W4284672912 creator A5048018285 @default.
• W4284672912 creator A5060627136 @default.
• W4284672912 creator A5068908789 @default.
• W4284672912 date "2022-07-01" @default.
• W4284672912 modified "2023-10-18" @default.
• W4284672912 title "Costs and Effects of Implementing Digital Tomosynthesis in a Population-Based Breast Cancer Screening Program: Predictions Using Results from the To-Be Trial in Norway" @default.
• W4284672912 cites W1846009810 @default.
• W4284672912 cites W1976812315 @default.
• W4284672912 cites W1983091263 @default.
• W4284672912 cites W2092183378 @default.
• W4284672912 cites W2092688199 @default.
• W4284672912 cites W2110262969 @default.
• W4284672912 cites W2111066681 @default.
• W4284672912 cites W2116825371 @default.
• W4284672912 cites W2122815913 @default.
• W4284672912 cites W2123869011 @default.
• W4284672912 cites W2137584842 @default.
• W4284672912 cites W2276152551 @default.
• W4284672912 cites W2308317855 @default.
• W4284672912 cites W2342018381 @default.
• W4284672912 cites W2514945210 @default.
• W4284672912 cites W2580074332 @default.
• W4284672912 cites W2586920444 @default.
• W4284672912 cites W2616443331 @default.
• W4284672912 cites W2782350534 @default.
• W4284672912 cites W2885655595 @default.
• W4284672912 cites W2889368834 @default.
• W4284672912 cites W2944306382 @default.
• W4284672912 cites W2944758817 @default.
• W4284672912 cites W2968564600 @default.
• W4284672912 cites W2972979332 @default.
• W4284672912 cites W2992183762 @default.
• W4284672912 cites W3020931746 @default.
• W4284672912 cites W3047002381 @default.
• W4284672912 cites W3140298982 @default.
• W4284672912 cites W3154031393 @default.
• W4284672912 cites W3156845110 @default.
• W4284672912 cites W3162046193 @default.
• W4284672912 cites W4225388971 @default.
• W4284672912 doi "https://doi.org/10.1007/s41669-022-00343-5" @default.
• W4284672912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35796950" @default.
• W4284672912 hasPublicationYear "2022" @default.
• W4284672912 type Work @default.
• W4284672912 citedByCount "1" @default.
• W4284672912 countsByYear W42846729122022 @default.
• W4284672912 crossrefType "journal-article" @default.
• W4284672912 hasAuthorship W4284672912A5009549265 @default.
• W4284672912 hasAuthorship W4284672912A5048018285 @default.
• W4284672912 hasAuthorship W4284672912A5060627136 @default.
• W4284672912 hasAuthorship W4284672912A5068908789 @default.
• W4284672912 hasBestOaLocation W42846729121 @default.
• W4284672912 hasConcept C112930515 @default.
• W4284672912 hasConcept C121608353 @default.
• W4284672912 hasConcept C126322002 @default.
• W4284672912 hasConcept C127454912 @default.
• W4284672912 hasConcept C147454874 @default.
• W4284672912 hasConcept C168563851 @default.
• W4284672912 hasConcept C18903297 @default.
• W4284672912 hasConcept C19527891 @default.
• W4284672912 hasConcept C2778491387 @default.
• W4284672912 hasConcept C2780472235 @default.
• W4284672912 hasConcept C2908647359 @default.
• W4284672912 hasConcept C2909182381 @default.
• W4284672912 hasConcept C3019080777 @default.
• W4284672912 hasConcept C530470458 @default.
• W4284672912 hasConcept C71924100 @default.
• W4284672912 hasConcept C72563966 @default.
• W4284672912 hasConcept C86803240 @default.
• W4284672912 hasConcept C99454951 @default.
• W4284672912 hasConceptScore W4284672912C112930515 @default.
• W4284672912 hasConceptScore W4284672912C121608353 @default.
• W4284672912 hasConceptScore W4284672912C126322002 @default.
• W4284672912 hasConceptScore W4284672912C127454912 @default.
• W4284672912 hasConceptScore W4284672912C147454874 @default.
• W4284672912 hasConceptScore W4284672912C168563851 @default.
• W4284672912 hasConceptScore W4284672912C18903297 @default.
• W4284672912 hasConceptScore W4284672912C19527891 @default.
• W4284672912 hasConceptScore W4284672912C2778491387 @default.
• W4284672912 hasConceptScore W4284672912C2780472235 @default.
• W4284672912 hasConceptScore W4284672912C2908647359 @default.
• W4284672912 hasConceptScore W4284672912C2909182381 @default.
• W4284672912 hasConceptScore W4284672912C3019080777 @default.
• W4284672912 hasConceptScore W4284672912C530470458 @default.
• W4284672912 hasConceptScore W4284672912C71924100 @default.
• W4284672912 hasConceptScore W4284672912C72563966 @default.
• W4284672912 hasConceptScore W4284672912C86803240 @default.
• W4284672912 hasConceptScore W4284672912C99454951 @default.
• W4284672912 hasFunder F4320310758 @default.
• W4284672912 hasFunder F4320323299 @default.
• W4284672912 hasIssue "4" @default.
• W4284672912 hasLocation W42846729121 @default.
• W4284672912 hasLocation W42846729122 @default.
• W4284672912 hasLocation W42846729123 @default.
• W4284672912 hasLocation W42846729124 @default.
• W4284672912 hasLocation W42846729125 @default.

• next